Shuzhen Ma Qi Dang Yali Yang Yongliang Liu Yuping Sun Meili Sun
10.3389/fonc.2020.526096
Front Oncol
2020 Oct 19;10:526096.
case report gastric cancer hypofibrinogenemia immunotherapy sintilimab
CC BY
https://pubmed.ncbi.nlm.nih.gov/33194584/
Case Reports
PMC7604326
33194584
Sintilimab, a PD-1 Inhibitor, Completely Reversed Rarely Refractory Hypofibrinogenemia in a Gastric Cancer Patient: A Case Report and Review of the Literature
2020